Anavex Life Sciences Corp (AVXL)

[JB3729]

The trial design doesn't include measurement of the MMSE score at 5 weeks, but, that doesn't mean that it wasn't taken.

This is an adaptive trial and AVXL, and those conducting the trial, may have wanted the 5 week interim info in order to determine dosage changes for the next patients.

I think the above is more likely than a typo.